Regulation of calcium-activated potassium efflux by neurotensin and other agents in HT-29 cells

Am J Physiol. 1991 Jan;260(1 Pt 1):C35-42. doi: 10.1152/ajpcell.1991.260.1.C35.

Abstract

Neurotensin receptors have been shown previously to be coupled to polyphosphoinositide turnover and intracellular Ca2+ ([Ca2+]i) mobilization in HT-29 colonic epithelial cells (Bozou et al. Biochem. J. 264: 871, 1989; Turner et al. J. Pharmacol. Exp. Ther. 253: 1049, 1990). In this study, neurotensin was found to enhance dramatically the Ba2(+)- and tetraethylammonium chloride-sensitive K(+)-efflux rate (measured with 86Rb+) in the presence of ouabain and bumetanide, with basal efflux increasing 4.5 +/- 0.5-fold with 10 nM neurotensin. The K(+)-efflux rate, which was partially dependent on the extracellular Ca2+ concentration, was also increased by carbachol and ATP, two other [Ca2+]i-mobilizing agonists in HT-29 cells, as well as by the Ca2+ ionophores ionomycin and A23187, suggesting that the efflux was through Ca2(+)-activated K+ channels. Pretreatment of cells with neurotensin, carbachol, or ATP desensitized subsequent neurotensin-stimulated efflux by 82, 57, and 63%, respectively, confirming our previous results which indicated homologous and heterologous desensitization of the neurotensin receptor-signal transduction pathway. Pretreatment of cells with the protein kinase C activators phorbol 12-myristate 13-acetate (PMA) and mezerein did not affect [Ca2+]i mobilization or K+ efflux directly but desensitized neurotensin-stimulated efflux by greater than 80%. Pretreatment (2 h) with PMA also decreased K+ efflux in response to ionomycin by 59%, although ionomycin-induced [Ca2+]i mobilization was not inhibited. Downregulation of protein kinase C by overnight pretreatment with PMA resulted in recovery of ionomycin-stimulated efflux. These results suggest that agonist-stimulated Ca2(+)-activated K+ channels in HT-29 cells are regulated at multiple steps in the signal transduction pathway.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma
  • Adenosine Triphosphate / pharmacology
  • Barium / pharmacology
  • Calcium / physiology*
  • Carbachol / pharmacology
  • Cell Line
  • Colonic Neoplasms
  • Humans
  • Ionomycin / pharmacology
  • Kinetics
  • Neurotensin / pharmacology*
  • Potassium / metabolism*
  • Potassium Channels / drug effects
  • Potassium Channels / physiology*
  • Rubidium / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tetraethylammonium
  • Tetraethylammonium Compounds / pharmacology

Substances

  • Potassium Channels
  • Tetraethylammonium Compounds
  • Barium
  • Neurotensin
  • Ionomycin
  • Tetraethylammonium
  • Adenosine Triphosphate
  • Carbachol
  • Rubidium
  • Tetradecanoylphorbol Acetate
  • Potassium
  • Calcium